DNA BRUSSELS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
DNA BRUSSELS
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1,205
2024 · -€470+€1,674
Equity
€48,245
2024 · €47,040+€1,205
Cash
-
not filed
Balance sheet total
€49,506
2024 · €48,702+€804
Largest movements
Assets
- Receivables within one year +€804
up €804 (+9.2%), from €8,702 to €9,506
Equity and liabilities
- Profit (loss) carried forward +€1,205
up €1,205 (+66.2%), from -€1,820 to -€615
Income statement
- Other operating charges -€1,711
no longer reported in 2025 (was €1,711)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€470
Other operating charges
+€1,711
Financial income
-€37
Result 2025
€1,205
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,702 | €49,506 | +€804 | +1.7% |
| Current assets | 29/58 | €48,702 | €49,506 | +€804 | +1.7% |
| Amounts receivable after more than one year | 29 | €40,000 | €40,000 | = | 0.0% |
| Other amounts receivable | 291 | €40,000 | €40,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €8,702 | €9,506 | +€804 | +9.2% |
| Other amounts receivable | 41 | €8,702 | €9,506 | +€804 | +9.2% |
| Total equity and liabilities | 10/49 | €48,702 | €49,506 | +€804 | +1.7% |
| Equity | 10/15 | €47,040 | €48,245 | +€1,205 | +2.6% |
| Contributions | 10/11 | €7,000 | €7,000 | = | 0.0% |
| Reserves | 13 | €41,860 | €41,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €40,000 | €40,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,820 | -€615 | +€1,205 | +66.2% |
| Amounts payable | 17/49 | €1,662 | €1,261 | -€401 | -24.1% |
| Amounts payable within one year | 42/48 | €1,662 | €1,261 | -€401 | -24.1% |
| Trade debts | 44 | €1,662 | €1,261 | -€401 | -24.1% |
| Suppliers | 440/4 | €1,662 | €1,261 | -€401 | -24.1% |
| Other operating charges | 640/8 | €1,711 | - | -€1,711 | |
| Operating profit (loss) | 9901 | -€1,711 | - | +€1,711 | |
| Financial income | 75/76B | €1,242 | €1,205 | -€37 | -3.0% |
| Recurring financial income | 75 | €1,242 | €1,205 | -€37 | -3.0% |
| Profit (loss) for the period before taxes | 9903 | -€470 | €1,205 | +€1,674 | |
| Profit (loss) for the period | 9904 | -€470 | €1,205 | +€1,674 | |
| Profit (loss) for the period to be appropriated | 9905 | -€470 | €1,205 | +€1,674 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.